Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.535 USD | +3.05% | +8.93% | +95.20% |
Apr. 16 | Lexaria Obtains Ethics Review Board Approval to Start New GLP-1 Study | MT |
Apr. 16 | Lexaria Bioscience Corp. Receives Ethics Review Board Approval to Begin New GLP-1 Study | CI |
- Stock Market
- Equities
- LEXX Stock
- News Lexaria Bioscience Corp.
- Analyst Reco.